
|Videos|November 9, 2015
Continuing Treatment in Dementia Patients
Kalin M. Clifford, PharmD, BCPS, discusses the factors should be considered when determining whether or not a patient with advanced dementia should continue taking a memantine or cholinesterase inhibitor.
Advertisement
Kalin M. Clifford, PharmD, BCPS, discusses the factors should be considered when determining whether or not a patient with advanced dementia should continue taking a memantine or cholinesterase inhibitor.
This video was recorded at ASCP's Annual Meeting and Exhibition in Las Vegas, Nevada in October 2015.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
TrumpRx Launches, Offering Cash-Paying Patients Discounted Drugs
2
SGLT2 Inhibitors in T2D Lower 5-Year Risk of CKD and Acute Kidney Injury
3
Enlicitide Meaningfully Lowers LDL-C at 24 Weeks in Patients At Risk for ASCVD Events
4
Pharmacist Takeover: CAR T Therapy Signals a Shift in ALL Treatment
5


























